Stereotaxis Corp (STXS): Utang-utang marang kapitalisasi buku

Tandha merek Stereotaxis Inc (STXS)

A stable engineering staff and the recruitment of programmers ensure the technological sovereignty of Stereotaxis, Inc. (STXS). The company's environmental development vector is evident in its energy-saving solutions and the reduction of plastics used in system assembly. The price trend reflected below, recorded at 0.31, complements the business outlook for the arrhythmia-fighting robotics venture, which relies on the expansion of the Genesis platform and new licenses.

STXS - Utang-utang marang aset resik Stereotaxis Corporation ing rentang 04.07.2022 - 27.10.2026
Produk asli Stereotaxis Inc

This indicator determines the proportion of borrowed funds within the equity structure, allowing investors to assess the degree of financial leverage and the risk of insolvency. By analyzing the total debt-to-book equity ratio, one can evaluate whether Stereotaxis, Inc. (STXS) possesses sufficient resources to scale the Genesis system and implement telemedicine solutions without imposing a critical debt burden on the business.

Pesaing Stereotaxis, Inc.

BSX: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku edwards.com EW|RMD: Utang-utang marang kapitalisasi buku|PODD - Utang marang nilai buku|Zimmer Biomet - Utang-utang marang kapitalisasi buku|CooperSurgical (COO) - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku GMED|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku Alphatec Holdings (ATEC)|Utang-utang marang kapitalisasi buku AORT|ENOV - Utang-utang marang aset resik|Utang marang nilai buku Integra LifeSciences|ESTA - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku BBNX|IRADIMED Corp (IRMD) - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Embecta Inc. (EMBC)|Rasio utang marang nilai buku Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Utang marang nilai buku|Rasio utang marang aset resik SIBN (si-bone.com)|Orthofix - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Bioventus Inc BVS|KIDS (OrthoPediatrics Inc.) - Utang-utang marang kapitalisasi buku|TMCI - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Strata Critical Medical Inc|carlsmed.com (CARL) - Rasio utang marang nilai buku|RXST: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik ClearPoint|Utang-utang marang kapitalisasi buku STIM (NeuroStar)|Utang marang nilai buku Sight Sciences Inc (SGHT)|Utang-utang marang kapitalisasi buku OBIO (Orchestra BioMed, Inc.)|Anika Therapeutics Inc. - Utang-utang marang kapitalisasi buku|NSPR - Rasio utang marang kapitalisasi buku|Jin Medical International (ZJYL) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku vivani.com VANI|Xtant Medical (XTNT) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku NMTC (NeuroOne Medical Technologies)|Utang-utang marang nilai buku MODD|MYO: Rasio utang marang kapitalisasi buku|Utang marang aset resik Envoy Medical Inc. COCH|Utang marang nilai buku VVOS (Vivos Therapeutics, Inc)|Utang-utang marang kapitalisasi buku enVVeno Corp NVNO|Utang-utang marang kapitalisasi buku SINT (SINTX Technologies)|TNON: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Lifeward (LFWD)|AMIX (Autonomix Medical) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku IVF|Utang marang nilai buku Bone Biologics Inc|Axonics, Inc. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku BIOL (biolase.com)|DYNT - Rasio utang marang kapitalisasi buku|FNA - Rasio utang marang nilai buku|Utang marang nilai buku INVO Bio INVO